Cencora/COR

$238.34

0.45%
-
1D1W1MYTD1YMAX

About Cencora

AmerisourceBergen Corporation is a global pharmaceutical sourcing and distribution services company. The Company's U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty. The Company also focuses on specialty services and a global platform of pharma manufacturer services capabilities.

Ticker

COR

Sector

Healthcare

Trading on

NYSE

Industry

Major Drugs

CEO

Steven Collis

Employees

39,000

Headquarters

Conshohocken, United States

Cencora Metrics

BasicAdvanced
$36.29B
Market cap
21.87
P/E ratio
$8.21
EPS
0.56
Beta
$1.92
Dividend rate
1.08%
Dividend yield

What the Analysts think about Cencora

Analyst Ratings

Majority rating from 17 analysts.
Buy

Price Targets

Average projection from 14 analysts.
12.07% downside
High $225.00
Low $190.00
$238.34
Current price
$209.57
Average price target

Cencora Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.71% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$66.95B
5.5%
Net income
$479.5M
10.13%
Profit margin
0.71%
4.41%

Cencora Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.56%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$2.60
$2.71
$3.50
$2.92
-
Expected
$2.57
$2.64
$3.29
$2.82
$2.79
Surprise
1.16%
2.77%
6.24%
3.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Cencora stock

Buy or sell Cencora stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing